Rohit I. Nijhawan

Rohit Nijhawan practices at Summit Medical Group Ambulatory Surgery Center - Berkeley Heights in Berkeley Heights, New Jersey.

Rohit Nijhawan's NPI, 1316237159, was assigned on April 13, 2011. Rohit Nijhawan graduated from Rush Medical College of Rush University in 2010. Rohit Nijhawan holds New Jersey license 25MA09469400.

Rohit Nijhawan's primary practice is Summit Medical Group Ambulatory Surgery Center - Berkeley Heights, at 1 Diamond Hill Road, Suite 1b-142, Berkeley Heights, NJ 07922. The practice phone is (908) 273-4300.

Rohit Nijhawan's primary practice is Summit Medical Group Ambulatory Surgery Center - Berkeley Heights in Berkeley Heights, New Jersey. The medical group on file is Summit Health. Dmand AI also links Rohit Nijhawan to 1 more group practice or clinic, named with a free account. Rohit Nijhawan's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Rohit Nijhawan practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Rohit Nijhawan's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Rohit Nijhawan is licensed in New Jersey.

CMS data shows 2,450 Medicare services from Rohit Nijhawan across 19 procedure codes in 2024, for 674 Medicare patients. Medicare paid $136,983 for them. Every service was in an office.

CMS counts 674 Medicare patients who saw Rohit Nijhawan in 2024. The largest group is 65 to 74, with 348 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Rohit Nijhawan's median patient age at 58, with 45% women.

In 2024, Rohit Nijhawan wrote 966 Medicare Part D claims for 397 patients. 89% of them were for generic drugs. CMS names the drug for 823 of them, across 22 drugs with 11 or more claims each, at $79,259 in total drug cost. In 2023, CMS named 590 claims across 15 drugs.

Rohit Nijhawan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 600 procedures of removal of skin lesions by Rohit Nijhawan, more than 88% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Rohit Nijhawan. Rohit Nijhawan's most frequent co-authors are Carrie Ann R. Cusack, MD and Alden M. Doyle, MD.

CMS Open Payments shows 48 general payments to Rohit Nijhawan from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Galderma Laboratories, L.P. paid the most, $1,067.

Rohit Nijhawan graduated from Rush Medical College of Rush University in 2010.